You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2026 › May › 31
Experimental
56 days ago
Those taking daraxonrasib lived for a median of 13.2 months compared with 6.7 months for chemotherapy recipients.
page 1 of 1